TY - JOUR
T1 - Use and outcome of minimally invasive pancreatic surgery in the European E-MIPS registry
AU - European Consortium on Minimally Invasive Pancreatic Surgery
AU - van der Heijde, Nicky
AU - Vissers, Frederique L.
AU - Manzoni, Alberto
AU - Zimmitti, Giuseppe
AU - Balsells, Joaquim
AU - Berrevoet, Frederik
AU - Bjornsson, Bergthor
AU - van den Boezem, Peter
AU - Boggi, Ugo
AU - Bratlie, Svein O.
AU - Burdio, Fernando
AU - Coratti, Andrea
AU - D'Hondt, Mathieu
AU - del Pozo, Carlos D.
AU - Dokmak, Safi
AU - Fara, Regis
AU - Can, Mehmet F.
AU - Festen, Sebastiaan
AU - Forgione, Antonello
AU - Fristrup, Claus
AU - Gaujoux, Sebastien
AU - Groot Koerkamp, Bas
AU - Hackert, Thilo
AU - Khatkov, Igor E.
AU - Keck, Tobias
AU - Seppänen, Hanna
AU - Lips, Daan
AU - Luyer, Misha
AU - Pittau, Gabriella
AU - Maglione, Manuel
AU - Molenaar, I. Quintus
AU - Pessaux, Patrick
AU - Roeyen, Geert
AU - Saint-Marc, Olivier
AU - Cabus, Santiago S.
AU - van Santvoort, Hjalmar
AU - van der Schelling, George
AU - Serradilla-Martin, Mario
AU - Souche, Francois-regis
AU - Suarez Muñoz, Miguel Á.
AU - Marino, Marco V.
AU - Besselink, Marc G.
AU - Abu Hilal, Mohammed
AU - Vilhav, Caroline
AU - Hartman, Vera
AU - Kirkegård, Jakob
AU - Sergeant, Gregory
AU - Kleeff, J. rg
AU - Coolsen, Marielle
AU - Coppola, Roberto
N1 - Funding Information: The E-MIPS registry is an investigator-initiated trial supported by unrestricted grants from Intuitive Surgical and Ethicon Surgical. The funders had no role in study design, data collection, data analysis, data interpretation, writing of the manuscript, and the decision to publish. Funding Information: This study was funded by a grant from Intuitive Surgical. Publisher Copyright: © 2022
PY - 2023/4/1
Y1 - 2023/4/1
N2 - Background: The European registry for minimally invasive pancreatic surgery (E-MIPS) collects data on laparoscopic and robotic MIPS in low- and high-volume centers across Europe. Methods: Analysis of the first year (2019) of the E-MIPS registry, including minimally invasive distal pancreatectomy (MIDP) and minimally invasive pancreatoduodenectomy (MIPD). Primary outcome was 90-day mortality. Results: Overall, 959 patients from 54 centers in 15 countries were included, 558 patients underwent MIDP and 401 patients MIPD. Median volume of MIDP was 10 (7–20) and 9 (2–20) for MIPD. Median use of MIDP was 56.0% (IQR 39.0–77.3%) and median use of MIPD 27.7% (IQR 9.7–45.3%). MIDP was mostly performed laparoscopic (401/558, 71.9%) and MIPD mostly robotic (234/401, 58.3%). MIPD was performed in 50/54 (89.3%) centers, of which 15/50 (30.0%) performed ≥20 MIPD annually. This was 30/54 (55.6%) centers and 13/30 (43%) centers for MIPD respectively. Conversion rate was 10.9% for MIDP and 8.4% for MIPD. Overall 90 day mortality was 1.1% (n = 6) for MIDP and 3.7% (n = 15) for MIPD. Conclusion: Within the E-MIPS registry, MIDP is performed in about half of all patients, mostly using laparoscopy. MIPD is performed in about a quarter of patients, slightly more often using the robotic approach. A minority of centers met the Miami guideline volume criteria for MIPD.
AB - Background: The European registry for minimally invasive pancreatic surgery (E-MIPS) collects data on laparoscopic and robotic MIPS in low- and high-volume centers across Europe. Methods: Analysis of the first year (2019) of the E-MIPS registry, including minimally invasive distal pancreatectomy (MIDP) and minimally invasive pancreatoduodenectomy (MIPD). Primary outcome was 90-day mortality. Results: Overall, 959 patients from 54 centers in 15 countries were included, 558 patients underwent MIDP and 401 patients MIPD. Median volume of MIDP was 10 (7–20) and 9 (2–20) for MIPD. Median use of MIDP was 56.0% (IQR 39.0–77.3%) and median use of MIPD 27.7% (IQR 9.7–45.3%). MIDP was mostly performed laparoscopic (401/558, 71.9%) and MIPD mostly robotic (234/401, 58.3%). MIPD was performed in 50/54 (89.3%) centers, of which 15/50 (30.0%) performed ≥20 MIPD annually. This was 30/54 (55.6%) centers and 13/30 (43%) centers for MIPD respectively. Conversion rate was 10.9% for MIDP and 8.4% for MIPD. Overall 90 day mortality was 1.1% (n = 6) for MIDP and 3.7% (n = 15) for MIPD. Conclusion: Within the E-MIPS registry, MIDP is performed in about half of all patients, mostly using laparoscopy. MIPD is performed in about a quarter of patients, slightly more often using the robotic approach. A minority of centers met the Miami guideline volume criteria for MIPD.
UR - http://www.scopus.com/inward/record.url?scp=85151563636&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.hpb.2022.07.015
DO - https://doi.org/10.1016/j.hpb.2022.07.015
M3 - Article
C2 - 37028826
SN - 1365-182X
VL - 25
SP - 400
EP - 408
JO - HPB
JF - HPB
IS - 4
ER -